Back
Intellia Therapeutics Stock Price Chart
The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.
Sell
24
NTLA
Intellia Therapeutics
Last Price:
$8.06
Seasonality Move:
22.72%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.77 | Buy |
| 20-day SMA: | 8.37 | Sell |
| 50-day SMA: | 7.93 | Buy |
| 200-day SMA: | 13.18 | Sell |
| 8-day EMA: | 7.91 | Buy |
| 20-day EMA: | 8.15 | Sell |
| 50-day EMA: | 8.42 | Sell |
| 200-day EMA: | 13.01 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 49.1 | Sell |
| Chaikin Money Flow: | 332773 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.49 - 9.11) | Sell |
| Bollinger Bands (100): | (7.62 - 10.32) | Sell |
Intellia Therapeutics Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 8.09 while NTLA 8-day simple moving average is 7.77, which is a Buy signal.
-
The stock price of NTLA is 8.09 while Intellia Therapeutics 20-day SMA is 8.37, which makes it a Sell.
-
Intellia Therapeutics 50-day simple moving average is 7.93 while NTLA share price is 8.09, making it a Buy technically.
-
NTLA stock price is 8.09 and Intellia Therapeutics 200-day simple moving average is 13.18, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
24
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $8.09. The Score for NTLA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
838M
Price in USD:
8.09
Share Volume:
7.2M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
5.90
Sell
24
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 8.09 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 8.09 while NTLA 8-day exponential moving average is 7.91, which is a Buy signal.
-
The stock price of NTLA is 8.09 while Intellia Therapeutics 20-day EMA is 8.15, which makes it a Sell.
-
Intellia Therapeutics 50-day exponential moving average is 8.42 while NTLA share price is 8.09, making it a Sell technically.
-
NTLA stock price is 8.09 and Intellia Therapeutics 200-day simple moving average is 13.01, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.09 per share, an increase this year of $1.12 per share, and an increase next year of $0.30 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Intellia Therapeutics is a Sell
-
Intellia Therapeutics Relative Strength Index (RSI) is 49.1, which suggest Intellia Therapeutics is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics is (7.49 - 9.11), which suggest Intellia Therapeutics is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.62 - 10.32), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.